Psychiatric News
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
Services
* Email this article to a Colleague
* Similar articles in this journal
* Alert me to new issues of the journal
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Search for Related Content
Psychiatric News January 19, 2001
Volume 36 Number 2
© 2001 American Psychiatric Association
p. 42


Professional News

Psychotropic Drugs on the FDA’s Priority List (Drug/Indication)

alprazolam/anxiety

amphetamine/ADHD

bupropion/depression

buspirone/anxiety

citalopram/depression

clomipramine/OCD

clozapine/psychotic disorders

divalproex/mania

fluoxetine/OCD and depression

lorazepam/anxiety

methylphenidate/ADHD

mirtazepine/depression

modafanil/ADHD

naltrexone/substance abuse

nefazodone/depression

olanzapine/psychotic disorders

oxazepam/anxiety

paroxetine/OCD and depression

pemoline/ADHD

quetiapine/psychotic disordes

risperidone/psychotic disorders

sertraline/OCD and depression

trazodone/depression

valproate/mania

venlafaxine/GAD and depression

Source: FDA; Center for Drug Evaluation and Research, December 2000





This Article
Services
* Email this article to a Colleague
* Similar articles in this journal
* Alert me to new issues of the journal
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Search for Related Content


Get information about faster international access.

Privacy Policy

Copyright © 2001 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org